Alpha-1 Antitrypsin Deficiency Market

Future Market Insights

Key Insight

The alpha-1 antitrypsin deficiency market is projected to grow from USD 3.8 billion in 2025 to USD 12.7 billion by 2035, at a CAGR of 12.8%. Augmentation Therapy will dominate with a 46.3% market share, while hospitals will lead the application segment with a 41.8% share.

August 23, 2025

Anurag Sharma

290 Pages

Cite this Report

Alpha-1 Antitrypsin Deficiency Market

https://www.futuremarketinsights.com/reports/alpha-1-antitrypsin-deficiency-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Kamada Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Alpha-1 Antitrypsin Deficiency Market

Key Players

Similar Industry Reports